Bacti Sode
NDC 83027-0152, Bacillus Tetani, Chlamydia Trachomatis, Colibacillinum Cum Natrum Muriaticum, Klebsiella Pneumoniae, Mycobacterium Paratuberculosis, Mycoplasma Pneumoniae, Pneumococcinum, Salmonella Typhi Nosode, Staphylococcus Aureus, Streptococcus Viridans, Pyrogenium, Pertussinum, Streptococcus Agalactiae, Streptococcus Dysgalactiae, Streptococcus Mutans, Bacillus Cereus, spray, from Nutritional Specialties, Inc..
- Product NDC
- 83027-0152
- Status
- Listed
- Labeler
- Nutritional Specialties, Inc.
- Dosage form
- SPRAY
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/83027-0152 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CLOSTRIDIUM TETANI20 [hp_X]/mL
- CHLAMYDIA TRACHOMATIS20 [hp_X]/mL
- ESCHERICHIA COLI20 [hp_X]/mL
- KLEBSIELLA PNEUMONIAE20 [hp_X]/mL
- MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS20 [hp_X]/mL
- MYCOPLASMA PNEUMONIAE20 [hp_X]/mL
- STREPTOCOCCUS PNEUMONIAE20 [hp_X]/mL
- SALMONELLA ENTERICA ENTERICA SEROVAR TYPHI20 [hp_X]/mL
- STAPHYLOCOCCUS AUREUS20 [hp_X]/mL
- STREPTOCOCCUS VIRIDANS GROUP20 [hp_X]/mL
- RANCID BEEF20 [hp_X]/mL
- HUMAN SPUTUM, BORDETELLA PERTUSSIS INFECTED30 [hp_X]/mL
- STREPTOCOCCUS AGALACTIAE15 [hp_C]/mL
- STREPTOCOCCUS DYSGALACTIAE15 [hp_C]/mL
- STREPTOCOCCUS MUTANS15 [hp_C]/mL
- BACILLUS CEREUS18 [hp_C]/mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 83027-0152-1 | 83027015201 | 60 mL in 1 BOTTLE, SPRAY (83027-0152-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 83027-0152 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/83027-0152 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 83027-0152. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.